سعر ستاركوبركس 5مجم 30 قرص 2024

Tadalafil 5 mg oral tablets, 30 per pack, marketed in Egypt by Multi-Apex; a phosphodiesterase type 5 (PDE5) inhibitor.

• Erectile dysfunction.Population: Adult menDailyMed (U.S. National Library of Medicine)
• Signs and symptoms of benign prostatic hyperplasia.Population: Adult menDailyMed (U.S. National Library of Medicine)
• Erectile dysfunction with signs and symptoms of BPH.Population: Adult menDailyMed (U.S. National Library of Medicine)

• Most common: headache, dyspepsia, back pain, myalgia, nasal congestion, flushing and pain in limb; postmarketing: serious cardiovascular events, hypersensitivity (including SJS), NAION, sudden hearing loss and priapism.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Use of any form of organic nitrate, regularly or intermittently (potentiates hypotensive effect).International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Known serious hypersensitivity to tadalafil (including SJS and exfoliative dermatitis reports).International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Concomitant guanylate cyclase stimulators such as riociguat.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Assess cardiovascular status; not for men in whom sexual activity is inadvisable; if nitrate is needed in a life-threatening situation, at least 48 hours should elapse after the last tadalafil dose.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Prolonged erection over 4 hours or priapism requires emergency care; caution with predisposing conditions or penile deformity.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Stop and seek care for sudden vision loss (possible NAION) or sudden hearing loss.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Organic nitratesContraindicated: tadalafil potentiates the hypotensive effect of nitrates.DailyMed (U.S. National Library of Medicine)
• Alpha-blockers (e.g., doxazosin, tamsulosin, alfuzosin) and antihypertensivesAdditive blood-pressure lowering; for ED start at the lowest dose in patients stable on alpha-blocker; combination not recommended for BPH.DailyMed (U.S. National Library of Medicine)
• Potent CYP3A4 inhibitors (ketoconazole, itraconazole, ritonavir)Increase tadalafil exposure; limit dose (10 mg every 72 h as needed; 2.5 mg once daily).DailyMed (U.S. National Library of Medicine)

• Not indicated for use in females; no data in pregnant women; no adverse developmental effects in rats or mice at up to 11 times the MRHD.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Not indicated for females; no information on presence in human milk; present in rat milk at about 2.4-fold plasma concentrations.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Tadalafil: Selective PDE5 inhibitor: enhances the nitric oxide/cGMP pathway, relaxing smooth muscle in the corpus cavernosum and in the prostate/bladder.